| Bioactivity | Lp-PLA2-IN-13 (compound 15) is a potent Lp-PLA2 inhibitor. Lp-PLA2-IN-13 has the potential for the research of neurodegenerative related diseases[1]. |
| Target | Lp-PLA2 |
| Name | Lp-PLA2-IN-13 |
| CAS | 2756855-62-4 |
| Formula | C22H17F5N4O4 |
| Molar Mass | 496.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. ZhengHua Gu, et al. Tricyclic pyrimidone compounds, preparation method, composition and application thereof. CN113861220A. |
Lp-PLA2-IN-13
CAS: 2756855-62-4 F: C22H17F5N4O4 W: 496.39
Lp-PLA2-IN-13 (compound 15) is a potent Lp-PLA2 inhibitor. Lp-PLA2-IN-13 has the potential for the research of neurodege
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.